February 3, 2023

Money News PH

The Premier Blog Where Money Talks

Movano’s New Smart Ring Focuses on Women’s Health • TechCrunch

Movano gets a week head start on what could prove to be banner CES for the Smart Ring. Today, the Bay Area-based company introduced Evie, a smart ring focused on women’s health, set to launch later next year. The device benefits from the recent popularity of the unobtrusive form factor, led by the likes of Oura and Circular.

However, it’s one of the first to focus on a specific market segment (as far as about 51% of the population can be considered a segment, I suppose). Women’s health makes perfect sense as a goal. Companies like Fitbit and Apple have had some success adding cycle tracking and related features.

This is of course included out of the box. Evie’s top level features include:

[R]Heart rate, heart rate variability, SpO2, respiration rate, skin temperature variability, period and ovulation tracking, menstrual symptom tracking, activity profile including steps, active minutes and calories burned, sleep phases and duration, and mood tracking.

The “mood” bit here is the main selling point of the yet-to-be-released Happy Ring, which uses its data to help users manage things like stress and sleep a little better. The rest of Evie’s details are still pretty hazy – Movano promises to take a closer look at the product at next week’s show. Of course, you can’t really blame the company for wanting to get ahead of the crowd.

Photo credit: Movano

Additionally, Movano says it plans to seek FDA approval for the product. Apparently there is no fixed schedule for this. It states:

The Company plans to submit an application for pulse oximetry metrics in October 2022 upon completion of a successful hypoxia study demonstrating clinical SpO2 and heart rate accuracy to the FDA consensus standard. While a few wearables are only FDA cleared for certain software like EKG and Afib, Evie is designed to regulatory standards and built in a medical device manufacturing facility that meets ISO13485 and cGMP standards. The release will provide women with trusted and personalized insights that can help them make connections between cause and effect so they can better understand the “why” behind their feelings. In addition, Evie will provide data that clinicians can trust for patient care.

That’s clearly the end game for many of these companies moving from the consumer space to something that’s taken a little more seriously by medical professionals, insurance companies and the like.

“As a medical device, Evie will surpass the status quo of other wearables on the market, and we believe it has the power to transform women’s lives and overall health,” said CEO John Mastrototaro in a press release. “We are bringing biometric data and medical-grade insights together in a convenient and contemporary wearable that empowers women to take control of their unique health journey.”

The product is expected to cost around $300 and unlike Oura, there will be no additional subscription fee.

Read more about CES 2023 on TechCrunch